Novo Nordisk's semaglutide ... ahead of other new products such as obesity drug Saxenda (liraglutide). Meanwhile, the start of phase III trials of oral semaglutide is also a boost for Novo ...

Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...

Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...